93 related articles for article (PubMed ID: 30484591)
1. Bioavailability of a fixed combination of intramuscular diclofenac 75 mg + thiocolchicoside 4 mg single dose vs. single components.
Imberti R; De Gregori S; Rabaglia L; Regazzi M
Minerva Med; 2019 Jun; 110(3):264-267. PubMed ID: 30484591
[No Abstract] [Full Text] [Related]
2. Comparative bioavailability and tolerability study of two intramuscular formulations of thiocolchicoside in healthy volunteers.
Ferrari MP; Gatti G; Fattore C; Fedele G; Novellini R
Eur J Drug Metab Pharmacokinet; 2001; 26(4):257-62. PubMed ID: 11808868
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of a fixed combination of intramuscular diclofenac 75 mg + thiocolchicoside 4 mg in the treatment of acute low back pain: a phase III, randomized, double blind, controlled trial.
Sproviero E; Albamonte E; Costantino C; Giossi A; Mancuso M; Rigamonti A; Tornari P; Caggiano G
Eur J Phys Rehabil Med; 2018 Oct; 54(5):654-662. PubMed ID: 29265793
[TBL] [Abstract][Full Text] [Related]
4. Single-dose bioavailability of oral and intramuscular thiocolchicoside in healthy volunteers.
Sandouk P; Bouvier d'Yvoire M; Chretien P; Tillement JP; Scherrmann JM
Biopharm Drug Dispos; 1994 Jan; 15(1):87-92. PubMed ID: 8161719
[TBL] [Abstract][Full Text] [Related]
5. Single- and repeated-dose pharmacokinetics of intramuscular thiocolchicoside in healthy volunteers.
Weinling E; Sandouk P; Debray M; Scherrmann JM
Int J Clin Pharmacol Ther; 1999 Oct; 37(10):503-9. PubMed ID: 10543318
[TBL] [Abstract][Full Text] [Related]
6. Single-dose and multiple-dose pharmacokinetics and dose proportionality of intravenous and intramuscular HPβCD-diclofenac (Dyloject) compared with other diclofenac formulations.
Mermelstein F; Hamilton DA; Wright C; Lacouture PG; Ramaiya A; Carr DB
Pharmacotherapy; 2013 Oct; 33(10):1012-21. PubMed ID: 23744759
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetics and biological availability of diclofenac preparations following intramuscular injection of 75 mg and oral administration of 150 mg of active drug].
Kurowski M
Z Rheumatol; 1988; 47(1):37-42. PubMed ID: 3369245
[TBL] [Abstract][Full Text] [Related]
8. To evaluate efficacy and safety of fixed dose combination of aceclofenac + paracetamol + thiocolchicoside (acenac-MR) in the treatment of acute low back pain.
Lahoti G
J Indian Med Assoc; 2012 Jan; 110(1):56-8. PubMed ID: 23029837
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of Transdermal Etofenamate and Diclofenac in Healthy Volunteers.
Drago S; Imboden R; Schlatter P; Buylaert M; Krähenbühl S; Drewe J
Basic Clin Pharmacol Toxicol; 2017 Nov; 121(5):423-429. PubMed ID: 28561421
[TBL] [Abstract][Full Text] [Related]
10. Skin atrophy caused by thiocolchicoside injections.
Guarneri F; Guarneri C; Cannavò SP
Int J Dermatol; 2006 Dec; 45(12):1473-4. PubMed ID: 17184273
[No Abstract] [Full Text] [Related]
11. Bioavailability of a formulation containing a diclofenac-ranitidine combination.
Carrasco-Portugal Mdel C; Aguilar-Cota ME; Pérez-Urizar J; Cabrera O; Herrera JE; Flores-Murrieta FJ
Proc West Pharmacol Soc; 2002; 45():8-10. PubMed ID: 12434510
[No Abstract] [Full Text] [Related]
12. Embolia cutis medicamentosa following thiocolchicoside injection.
Guarneri C; Polimeni G; Guarneri F; Cuzzocrea S
J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):1005-6. PubMed ID: 18070022
[No Abstract] [Full Text] [Related]
13. Bioavailability of diclofenac potassium at low doses.
Hinz B; Chevts J; Renner B; Wuttke H; Rau T; Schmidt A; Szelenyi I; Brune K; Werner U
Br J Clin Pharmacol; 2005 Jan; 59(1):80-4. PubMed ID: 15606444
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of diclofenac & thiocolchioside gel phonophoresis comparison with ultrasound therapy on acute low back pain; a prospective, double-blind, randomized clinical study.
Altan L; Kasapoğlu Aksoy M; Kösegil Öztürk E
Ultrasonics; 2019 Jan; 91():201-205. PubMed ID: 30139568
[TBL] [Abstract][Full Text] [Related]
15. New metabolic and pharmacokinetic characteristics of thiocolchicoside and its active metabolite in healthy humans.
Trellu M; Filali-Ansary A; Françon D; Adam R; Lluel P; Dubruc C; Thénot JP
Fundam Clin Pharmacol; 2004 Aug; 18(4):493-501. PubMed ID: 15312157
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety Profile of Diclofenac/Cyclodextrin and Progesterone/Cyclodextrin Formulations: A Review of the Literature Data.
Scavone C; Bonagura AC; Fiorentino S; Cimmaruta D; Cenami R; Torella M; Fossati T; Rossi F
Drugs R D; 2016 Jun; 16(2):129-40. PubMed ID: 26939533
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and drug input characteristics for a diclofenac-codeine phosphate combination following oral and rectal administration.
Hanses A; Spahn-Langguth H; Meiss F; Mutschler E
Arzneimittelforschung; 1996 Jan; 46(1):57-63. PubMed ID: 8821519
[TBL] [Abstract][Full Text] [Related]
18. Determination of the transdermal bioavailability of a newly developed diclofenac sodium patch in comparison with a reference preparation.
Gschwend MH; Martin W; Arnold P; Verdun MO; Cambon N; Frentzel A; Scheiwe W
Arzneimittelforschung; 2005; 55(7):403-13. PubMed ID: 16080280
[TBL] [Abstract][Full Text] [Related]
19. Comparative bioavailability of two suspension formulations of potassium diclofenac in healthy male volunteers.
Mendes GB; Franco LM; Moreno RA; Fernandes AG; Muscara MN; de Nucci G
Int J Clin Pharmacol Ther; 1994 Mar; 32(3):131-5. PubMed ID: 8205374
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of a new subcutaneous diclofenac formulation administered to three body sites: quadriceps, gluteus, and abdomen.
Salomone S; Piazza C; Vitale DC; Cardì F; Gugliotta B; Drago F
Int J Clin Pharmacol Ther; 2014 Feb; 52(2):129-34. PubMed ID: 24361086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
